Results 121 to 130 of about 950,946 (355)

Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer

FEBS Open Bio, EarlyView.
A novel signature integrating genome‐wide analysis with clinical factors predicts recurrence in stage II colorectal cancer and enables a new risk stratification to guide postoperative adjuvant chemotherapy. Clinical risk stratification for postoperative recurrence in patients with pathological stage II (pStage II) colorectal cancer (CRC) is essential ...
Mayuko Otomo, Keisuke Okuno, Shuichi Watanabe, Sakiko Oba, Hiroyasu Kagawa, Masanori Tokunaga, Daisuke Ban, Yusuke Kinugasa   +7 more
wiley   +1 more source

Improved Weed Control Methods in Maize (Zea mays L.) By Using Single Herbicides and Their Combinations at Reduced Rates with Mineral Oil Adjuvant [PDF]

, 2017
W. Aref, R Dawood, Anaam Galal, Z. R. Yehia, H Abouzinea, M Ahmed, M Eldabaa, M Abd El Wahed, A Amin, M Khan, G Hassan, K Marwat, H Rashid, K Nawab, F Bashir, M Nadeem, A Tanveer, T Abbas, I Bodgan, P Gus, T Rusu, A Pop, A Vaju, P Morar, N Costa, D Martins, R Rodella, L De Camargo Da, Costa, J Ditomaso, M Dogan, O Boz, A Unay, B Duncan, J Green, A Hassan, M Ahmed, R Idziak, Z Woznica, E Kandil, A Kordy, K Kir, M Dogan, M Knezevic, M Durkic, I Knezevic, Z Loncaric, A Marzouk, M Nadeem, R Ahmad, M Khalid, M Naveed, A Tanveer, J Ahmad, E Pannacci, F Graziani, G Covarelli, E Pannacci, A Onofri, V Patel, P Upadhyay, J Patel, B Patel, H Saudy, F Sharara, T El-Shahawy, K El-Rokiek, P Sikkema, R Nurse, T Welacky, A Hamill, V Sostarcic, M Scepanovic, K Baric, H Sulewska, W Koziara, K miatacz, G Szymaska, K Panasiewicz, A Tesfay, M Amin, N Mulugeta, Z Woznica, R Idziak   +83 more
openalex   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Adjuvant chemotherapy options for early stage non-small cell lung cancer

Frontiers in Oncology, 2011
For many years adjuvant chemotherapy has been a standard treatment after complete resection in malignancies such as breast and colon but only recently has its use become standard in early stage non-small cell lung cancer (NSCLC).
Manali ePatel, Heather A Wakelee
doaj   +1 more source

Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer [PDF]

, 2011
Philip Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh   +9 more
openalex   +1 more source

Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer

Aging and Cancer, EarlyView.
Women threated with adjuvant chemotherapy for early breast cancer have sustained long‐term increase in p16INK4a,, a robust marker of cell senescence, suggesting a chemotherapy‐associated age acceleration. p16INK4a as well as other biomarkers may identify patients at greatest risk for senescence‐related diseases of aging.
Hyman B. Muss, Alexis C. Wardell, Allison M. Deal, Kirsten A. Nyrop, Allison Ross, Yara G. Abdou, Jeffrey D. Aldrich, Lisa A. Cary, E. Claire Dees, Katherine E. Reeder‐Hayes, Emily M. Ray, Natalia Mitin, Denis Tsygankov   +12 more
wiley   +1 more source

Re: Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective [PDF]

, 2006
Ian Kunkler, Nicola S. Russell, Peter Canney, Karen Venables, John M.S. Bartlett   +4 more
openalex   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Aging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel, S. Tissera, E. Paul, J. Zalcberg, R. G. Stirling   +4 more
wiley   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source